PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis

Blood

Volumn 104, Issue 10, 2004, Pages 3198-3204

  Uutela, Marko ^b   Wirzenius, Maria ^b   Paavonen, Karri ^b   Rajantie, Iiro ^b   He, Yulong ^b   Karpanen, Terhi ^b   Lohela, Marja ^b   Wiig, Helge ^b   Salven, Petri ^b   Pajusola, Katri ^b   Eriksson, Ulf ^b   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR D; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN E;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL; CELL DENSITY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERICYTE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TISSUE PRESSURE; UPREGULATION; WOUND HEALING;

EID: 8644226222     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-04-1485     Document Type: Article

References (40)

1. Heldin C-H, Westermark B, Wasteson Å. Platelet-derived growth factor: purification and partial characterization. Proc Natl Acad Sci U S A. 1979;76:3722-3726.
2. Heldin C-H, Westermark B. Mechanism of action and in vivo role of platelet derived growth factor. Physiol Rev. 1999;79:1283-1316.
3. Li X, Pontén A, Aase K, et al. PDGF-C is a new prolease-activated ligand for the PDG F-a receptor. Nat Cell Biol. 2000;2:302-309.
4. Bergsten E, Uutela M, Li X, et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol. 2001;3:512-516.
5. Uutela M, Laurén J, Bergsten E, et al. Chromosomal location, exon structure and vascular expression patterns of the human PDGFC and PDGFD genes. Circulation. 2001;103:2242-2247.
6. LaRochelle WJ, Jeffers M, McDonald WF, et al. PDGF-D, a new protease-activated growth factor. Nat Cell Biol. 2001;3:517-521.
7. Ustach CV, Taube ME, Hurst NJJ, et al. A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression. Cancer Res. 2004;64:1722-1729.
8. LaRochelle WJ, Jeffers M, Corvalan JR, et al. Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer. Cancer Res. 2002;62:2468-2473.
9. Li H, Fredriksson L, Li X, Eriksson, U. PDGF-D is a potent transforming and angiogenic growth factor. Oncogene. 2003;22:1501-1510.
10. Ostendorf T, van Roeyen CR, Peterson JD, et al. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J Am Soc Nephrol. 2003;14:2237-2247.
11. Martin P. Wound healing - aiming for perfect skin regeneration. Science. 1997;276:75-81.
12. Ross R, Masuda J, Raines E, et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science. 1990;248:1009-1012.
13. Buetow B, Crosby J, Kaminski W, et al. Platelet-derived growth factor B-chain of hematopoietic origin is not necessary for granulation tissue formation and its absence enhances vascularization. Am J Pathol. 2001;159:1869-1876.
14. Werner S, Munz B. Suppression of keratin 15 expression by transforming growth factor beta in vitro and by cutaneous injury in vivo. Exp Cell Res. 2000;254:80-90.
15. Vassar R, Rosenberg M, Ross S, Tyner A, Fuchs E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci U S A. 1989;86:1563-1567.
16. Paterna JC, Moccetti T, Mura A, Feldon J, Bueler H. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther. 2000;7:1304-1311.
17. Karkkainen MJ, Saaristo A, Jussila L, et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A. 2001;98:12677-12682.
18. Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7:199-205.
19. Fukumura D, Salehi HA, Witwer B, Tuma RF, Medler RJ, Jain RK. Tumor necrosis factor α-induced leucocyte adhesion in normal and tumor vessel: effect of tumor type, transplantation site, and host strain. Cancer Res. 1995;55:4824-4829.
20. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997;407:313-319.
21. Iivanainen A, Kortesmaa J, Sahlberg C, et al. Primary structure, developmental expression, and immunolocalization of the murine laminin alpha4 chain. J Biol Chem. 1997;272:27862-27868.
22. Kubo H, Fujiwara T, Jussila L, et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood. 2000;96:546-553.
23. Laakkonen P, Porkka K, Hoffman JA, Ruoslahti E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med. 2002;8:751-755.
24. Saaristo A, Veikkola T, Tammela T, et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med. 2002;196:719-730.
25. Fadnes HO, Reed RK, Aukland K. Interstitial fluid pressure in rats measured with a modified wick technique. Microvasc Res. 1977;14:27-36.
26. Rehli M, Krause SW, Schwarzfischer L, Kreutz M, Andreesen R. Molecular cloning of a novel macrophage maturation-associated transcript encoding a protein with several potential transmembrane domains. Biochem Biophys Res Commun. 1995;217:661-667.
27. Wiig H. Evaluation of methodologies for measurement of interstitial fluid pressure (Pi): physiological implications of recent Pi data. Crit Rev Biomed Eng. 1990;18:27-54.
28. Jain RK. Barriers to drug delivery in solid tumors. Sci Am. 1994;271:58-65.
29. Rodt SA, Ahlen K, Berg A, Rubin K, Reed RK. A novel physiological function for platelet-derived growth factor-BB in rat dermis. J Physiol. 1996;495:193-200.
30. Pietras K, Ostman A, Sjoquist M, et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res. 2001;61:2929-2934.
31. Pietras K, Rubin K, Sjoblom T, et al. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res. 2002;62:5476-5484.
32. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem. 1991;45:319-326.
33. Fang L, Yan Y, Komuves LG, et al. PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle. Arterioscler Thromb Vasc Biol. 2004;24:787-792.
34. Saharinen P, Alitalo K. Double target for tumor mass destruction. J Clin Invest. 2003;111:1277-1280.
35. Siegbahn A, Hammacher A, Westermark B, Heldin CH. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest. 1990;85:916-920.
36. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science. 1988;241:708-712.
37. Leibovich SJ, Ross R. The role of the macrophage in wound repair: a study with hydrocortisone and antimacrophage serum. Am J Pathol. 1975;78:71-100.
38. Antoniades H, Galanopoulos T, Neville-Golden J, Kiritsy C, Lynch SE. Injury induces in vivo expression of platelet-derived growth factor (PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts. Proc Natl Acad Sci U S A. 1991;88:565-569.
39. Reuterdahl C, Sundberg C, Rubin K, Funa K, Gerdin B. Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans. J Clin Invest. 1993;91:2065-2075.
40. Kiba A, Sagara H, Hara T, Shibuya M. VEGFR-2 - specific ligand VEGF-E induces non-edematous hyper-vascularization in mice. Biochem Biophys Res Commun. 2003;301:371-377.